Reduced versus standard dose apixaban for secondary prevention of cancer-associated venous thromboembolism: A systematic review and meta-analysis
Authors
- Shreya Patel (ORCID: https://orcid.org/0000-0001-5725-3832)
- Devesh Amin
- Vasu Malhotra
- Ardit Feinaj (ORCID: https://orcid.org/0000-0003-1445-4241)
- Michael Sabina (ORCID: https://orcid.org/0009-0007-2041-623X)
- Muhammad Zain Farooq
- Hiralal Ash
- Jennifer Trube (ORCID: https://orcid.org/0009-0001-9815-5582)
- ZACHARY BRESLOW (ORCID: https://orcid.org/0009-0005-5486-9574)
- Mohammad Boozo
Institutions
- Southern Illinois University School of Medicine (US)
- Lakeland Regional Medical Center (US)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-12-19
- DOI
- https://doi.org/10.3389/fonc.2025.1690984
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00